This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hansen Medical 3Q Loss Narrows On Lower Costs

MOUNTAIN VIEW, Calif. (AP) ¿ Hansen Medical Inc., which makes medical robotic technology used with catheters, said Monday its third-quarter loss narrowed as the company lowered costs.

Hansen said it lost $11.9 million, or 32 cents per share, compared with a loss of $12.9 million, or 51 cents per share a year earlier. Per-share results in the most recent quarter were based on about 12 million additional shares of common stock.

Revenue fell sharply to $4.6 million from $9.6 million.

Analysts polled by Thomson Reuters had forecast a loss of 33 cents per share and revenue of $5.8 million, on average.

"The current economic environment continues to create challenges in expanding the sale of capital equipment in the early stages of commercialization like our Sensei Robotic Catheter System," said President and CEO Dr. Frederic Moll, in a statement.

The company said it recognized revenue on the sale of five Sensei Robotic Systems, and shipped five others. Hansen also sold 497 Artisan Control Catheters in the third quarter.

Operating expenses fell 19 percent to $13 million from $16.2 million.

Shares of Hansen rose 9 cents, or 3.2 percent, to $2.82 in after-hours trading after shedding 27 cents, or 9 percent, to close at $2.73 during the regular trading session.

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
HNSN $0.89 0.00%
AAPL $130.28 0.00%
FB $81.53 0.00%
GOOG $565.06 0.00%
TSLA $218.42 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs